Please assess the completion status of the following clinical trial:

Trial Title: Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ≥18 years~* Inpatient-treated patients with acute volume overload, preferably in association with cardiac decompensation with signs of incipient diuretic resistance (lack of increase in urine output despite significant escalation of diuretic therapy; e.g. ≥80 mg furosemide / 24 h or less than 1375 mL urine output/40 mg furosemide per 24 h or equivalent dose of other loop diuretics \[established clinically or from the medical history\])~* New York Association Functional Class (NYHA) III-IV at inclusion~* Systolic or diastolic cardiac dysfunction (HF-REF or HF-PEF)~* Adequate venous access (preferably peripheral arm vein) allowing a flow rate ≥ 60 mL / min~* Written consent to the use of data in the registry (where necessary, by a legal guardian).~Exclusion Criteria:~* Contraindication to anticoagulation (e.g. known heparin-induced thrombocytopenia, severe bleeding)~* Terminal renal failure (stage V, GFR \<15 mL)~* Cardiogenic shock, e.g. in association with acute coronary syndrome (ACS)~* Other diseases or factors that, in the study doctor's opinion, constitute a potential contraindication to ultrafiltration~* Pregnant women, women in labour, breast-feeding women or women of childbearing potential, who are without adequate contraception or are planning a family. NB: a pregnancy test is performed systematically in women of childbearing age and the patient is not included in the event of pregnancy (positive test). It is absolutely essential that women, who have a negative test and who are included in the study, have an effective contraception.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- periph. minimal invasive ultrafiltration (Type: None): Patients with volume overload receiving ultrafiltration

Based on this trial design, predict the completion outcome and termination type (if applicable).